Major depressive disorder with anger: A bipolar spectrum disorder?

Psychotherapy and Psychosomatics

Volumn 72, Issue 6, 2003, Pages 300-306

  Benazzi, Franco ^a,b,c,d,e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Collaborating Center ^*  (Italy)

^c National Health Service ^*  (Italy)

^d DEPARTMENT OF PSYCHIATRY   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f NONE   (Italy)

Author keywords

Anger; Bipolar II disorder; Bipolar spectrum; Depression; Major depressive disorder

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ANGER; ARTICLE; BIPOLAR DISORDER; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; HYPOMANIA; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; ONSET AGE; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; AGE FACTORS; ANGER; BIPOLAR DISORDER; CALIFORNIA; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; ODDS RATIO; PSYCHOMETRICS; SEX FACTORS;

EID: 0142089128     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073026     Document Type: Article

References (72)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR), ed 4. Washington, American Psychiatric Association, 2000.
2. Goodwin FK, Jamison KR: Manic-Depressive Illness. New York, Oxford University Press, 1990.
3. Dayer A, Aubry J-M, Roth L, Ducrey S, Bertschy G: A theoretical reappraisal of mixed states: Dysphoria as a third dimension. Bipolar Disord 2000;2:316-324.
4. Koukopoulos A, Koukopoulos A: Agitated depression as a mixed state and the problem of melancholia. Psychiatr Clin North Am 1999;22:547-564.
5. Akiskal HS, Pinto O: The evolving bipolar spectrum: Prototypes I, II, III, and IV. Psychiatr Clin North Am 1999;22:517-534.
6. Benazzi F, Akiskal HS: Delineating bipolar II mixed states in the Ravenna-San Diego collaborative study: The relative prevalence and diagnostic significance of hypomanic features during major depressive episodes. J Affect Disord 2001;67:115-122.
7. Perugi G, Akiskal HS, Micheli C, Musetti L, Paiano A, Quilici C, Rossi L, Cassano GB: Clinical subtypes of bipolar mixed states: Validating a broader European definition in 143 cases. J Affect Disord 1997;43:169-180.
8. Perugi G, Akiskal HS, Micheli C, Toni C, Madaro D: Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. J Affect Disord 2001;67:105-114.
9. Fava M, Anderson K, Rosenbaum JF: 'Anger attacks': Possible variants of panic and major depressive disorders. Am J Psychiatry 1990;147:867-870.
10. Fava M, Rosenbaum JF, Pava JA, McCarthy MK, Steingard RJ, Bouffides E: Anger attacks in unipolar depression. 1. Clinical correlates and response to fluoxetine treatment. Am J Psychiatry 1993;150:1158-1163.
11. Fava M, Rosenbaum JF: Anger attacks in patients with depression. J Clin Psychiatry 1999:60(suppl 15):21-24.
12. Posternak MA, Zimmerman M: Anger and aggression in psychiatric outpatients. J Clin Psychiatry 2002;63:665-672.
13. Perlis RH, Smoller JW, Racette S, Roffi PA, Rubenstein GEF, Sachs GS, Fava M: A comparison of the prevalence and correlates of anger attacks in bipolar disorder (abstract No 20:9). 155th Annu Meet Am Psychiatr Assoc, Philadelphia, May 18-23, 2002.
14. Tedlow J, Leslie V, Keefe BR, Alpert J, Nierenberg AA, Rosenbaum JF, Fava M: Axis I and axis II disorder comorbidity in unipolar depression with anger attacks. J Affect Disord 1999;52:217-223.
15. Baldessarini RJ: Drugs and the treatment of psychiatric disorders. Depression and anxiety, in Hardman JG, Limbird LE, Goodman Gilman A (eds): Goodman & Gilman's The Pharmacological Basis of Therapeutics, ed 10. New York, McGraw-Hill, 2001, pp 447-483.
16. Akiskal HS: Classification, diagnosis and boundaries of bipolar disorders: A review; in Maj M, Akiskal HS, Lopez-Ibor JJ, Sartorius N (eds): Bipolar Disorder. Chichester, Wiley, 2002, pp 1-52.
17. Bowden CL: Pharmacological treatment of bipolar disorder: A review; in Maj M, Akiskal HS, Lopez-Ibor JJ, Sartorius N (eds): Bipolar Disorder. Chichester, Wiley, 2002, pp 191-221.
18. Moller H-J, Grunze H: Antidepressant treatment of bipolar depression; in Marneros A, Angst J (eds): Bipolar Disorders: 100 Years after Manic-Depressive Insanity. Dordrecht, Kluver Academic Publishers, 2000, pp 387-403.
19. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L: Antidepressant-induced mania and cycle acceleration: A controversy revisited. Am J Psychiatry 1995;152:1130-1138.
20. Benazzi F: Antidepressant-associated hypomania in outpatient depression: A 203-case study in private practice. J Affect Disord 1997;46:73-76.
21. Maris RW: Suicide. Lancet 2002;360:319-326.
22. Ghaemi SN, Ko JY, Goodwin FK: 'Cade's disease' and beyond: Misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry 2002;47:125-134.
23. Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon M: Bipolar outcome in the course of depressive illness: Phenomenologic, familial, and pharmacologic predictors. J Affect Disord 1983;5:115-128.
24. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W: Toward a re-definition of sub-threshold bipolarity: Epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 2003;73:133-146.
25. Benazzi F: Sensitivity and specificity of clinical markers for the diagnosis of bipolar II disorder. Compr Psychiatry 2001;42:461-465.
26. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H-J, Hirschfeld R: Re-evaluating the prevalence and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 2000;59(suppl 1):S5-S30.
27. Baldessarini RJ: A plea for integrity of the bipolar disorder concept. Bipolar Disord 2000;2:3-7.
28. McMahon FJ, Stine OC, Chase GA, Meyers DA, Simpson SG, DePaulo JR: Influence of clinical subtype, sex, and lineality on age at onset of major affective disorder in a family sample. Am J Psychiatry 1994;151:210-215.
29. Akiskal HS, Benazzi F: Family history validation of the bipolar nature of depressive mixed states. J Affect Disord 2003;73:113-122.
30. Angst J: The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998;50:143-151.
31. Benazzi F: Prevalence of bipolar II disorder in outpatient depression: A 203-case study in private practice. J Affect Disord 1997;43:63-66.
32. Benazzi F: Bipolar II depression in late life: Prevalence and clinical features in 525 depressed outpatients. J Affect Disord 2001;66:13-18.
33. Benazzi F, Akiskal HS: Refining the evaluation of bipolar II: Beyond the strict SCID-CV guidelines for hypomania. J Affect Disord 2003;73:33-38.
34. Hantouche EG, Akiskal HS, Lencrenon S, Allilaire J-F, Sechter D, Azorin J-M, Bourgeois M, Fraud J-P, Chatenet-Duchene L: Systematic clinical methodology for validating bipolar-II disorder: Data in mid-stream from a french national multi-site study (EPIDEP). J Affect Disord 1998;50:163-173.
35. Cassano GB, Akiskal HS, Savino M, Musetti L, Perugi G, Soriani A: Proposed subtypes of bipolar II and related disorders: With hypomanic episodes (or cyclothymia) and with hyperthymic temperament. J Affect Disord 1992;26:127-140.
36. Perugi G, Akiskal HS, Lattanzi L, Cecconi D, Mastrocinque C, Patronelli A, Vignoli S, Bemi E: The high prevalence of 'soft' bipolar (II) features in atypical depression. Compr Psychiatry 1998;39:63-71.
37. Angst J: Comorbidity of mood disorders: A longitudinal prospective study. Br J Psychiatry 168;30(suppl):31-37.
38. Ghaemi SN: Dr. Ghaemi replies. High prevalence of bipolar spectrum disorders, by Benazzi F. J Clin Psychiatry 2001;62:735-736.
39. Goldberg JF, Kocsis JH: Depression in the course of bipolar disorder; in Goldberg JF, Harrow M (eds): Bipolar Disorders. Clinical course and outcome. Washington, American Psychiatric Press, 1999, pp 129-147.
40. Ghaemi SN, Boiman EE, Goodwin FK: Diagnosing bipolar disorder and the effect of antide-pressants: A naturalistic study. J Clin Psychiatry 2000;61:804-808.
41. Post RM, Nolen WA, Kupka RW, Denicoff KD, Leverich GS, Keck PE, McElroy SL, Rush AJ, Suppes T, Altshuler LL, Frye MA, Grunze H, Walden J: The Stanley Foundation Bipolar Network. 1. Rationale and methods. Br J Psychiatry 2001;178:S169-S176.
42. Benazzi F: Borderline personality disorder and bipolar II disorder in private practice depressed outpatients. Compr Psychiatry 2000;41:106-110.
43. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician version (SCID-CV). Washington, American Psychiatric Press, 1997.
44. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
45. Williams JBW, Terman M, Link MJ, Amira L, Rosenthal NE: Hypomania interview guide (including hyperthymia). Current Assessment Version (HIGH-C). Norwood, Clinical Assessment Tools Packet, Center for Environmental Therapeutics, 1994 (rev 2000).
46. Williams JBW, Terman M, Link MJ, Amira L, Rosenthal NE: Hypomania interview guide (including hyperthymia): Retrospective assessment version (HIGH-R). Depress Anxiety 1999;9:92-100.
47. Weissman MM, Wickramaratne P, Adams P, Wolk S, Verdeli H, Olfson M: Brief screening for family psychiatric history. The family history screen. Arch Gen Psychiatry 2000;57:675-682.
48. Dunner DL: Diagnostic revisions for DSM-IV; in Goodnick PL (ed): Mania. Clinical and Research Perspectives. Washington, American Psychiatric Press, 1998, pp 3-10.
49. Benazzi F: Is 4 days the minimum duration of hypomania in bipolar II disorder? Eur Arch Psychiatry Clin Neurosci 2001;251:32-34.
50. Akiskal HS: The prevalent clinical spectrum of bipolar disorders: Beyond DSM-IV. J Clin Psychopharmacol 1996;16(suppl 1):4S-14S.
51. Akiskal HS, Djenderedjian AH, Rosenthal RH, Khani MK: Cyclothymic disorder: Validating criteria for inclusion in the bipolar affective group. Am J Psychiatry 1977;134:1227-1233.
52. Coryell W, Endicott J, Maser JD, Keller MB, Leon AC, Akiskal HS: Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry 1995;152:385-390.
53. Mitchell PB, Wilhelm K, Parker G, Austin MP, Rutgers P, Malhi GS: The clinical features of bipolar depression: A comparison with matched major depressive disorder patients. J Clin Psychiatry 2001;62:212-216.
54. Coryell W: Bipolar II disorder: The importance of hypomania; in Goldberg JF, Harrow M (eds): Bipolar Disorders. Clinical course and outcome. Washington, American Psychiatric Press, 1999, pp 219-236.
55. Robins E, Guze SB: Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. Am J Psychiatry 1970;126:983-987.
56. Kendler KS: The nosologic validity of paranoia (simple delusional disorder). Arch Gen Psychiatry 1980;37:699-706.
57. Kendler KS: Toward a scientific psychiatric nosology. Strengths and limitations. Arch Gen Psychiatry 1990;47:969-973.
58. Joffe RT, Young LT, MacQeen GM: A two-illness model of bipolar disorder. Bipolar Disord 1999;1:25-30.
59. Baldessarini RJ, Ghaemi NS, Viguera AC: Tolerance in antidepressant treatment. Psychother Psychosom 2002;71:177-179.
60. Schmidt ME, Fava M, Zhang S, Gonzales J, Raute NJ, Judge R: Treatment approaches to major depressive disorder relapse. 1. Dose increase. Psychother Psychosom 2002;71:190-194.
61. Fava M, Schmidt ME, Zhang S, Gonzales J, Raute NJ, Judge R: Treatment approaches to major depressive disorder relapse. 2. Reinitiation of antidepressant treatment. Psychother Psychosom 2002;71:195-199.
62. Akiskal HS, Mallya G: Criteria for the 'soft' bipolar spectrum: Treatment implications. Psychopharmacol Bull 1987;23:68-73.
63. Dunner DL, Tay KL: Diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression. Compr Psychiatry 1993;34:303-307.
64. Brugha TS, Jenkins R, Taub N, Meltzer H, Bebbington PE: A general population comparison of the Composite International Diagnostic Interview (CIDI) and the Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Psychol Med 2001;31:1001-1013.
65. Simpson SG, McMahon FJ, McInnis MG, MacKinnon DF, Edwin D, Folstein SE, De-Paulo JR: Diagnostic reliability of bipolar II diagnosis. Arch Gen Psychiatry 2002;59:736-740.
66. American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159(4 Suppl):1-50.
67. Kraepelin E: Manic-Depressive Insanity and Paranoia. Edinburgh, Livingstone, 1921.
68. Kupfer DJ, Frank E, Grochocinski VJ, Cluss PA, Kouck PR, Stapf DA: Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry 2002;63:120-125.
69. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, McElroy SL, Rush AJ, Kupka RW, Frye MA, Bickel M, Post RM: The Stanley Foundation Bipolar Treatment Outcome Network. 2. Demographics and illness characteristics of the first 261 patients. J Affect Disord 2001;67:45-59.
70. Kupfer DJ, Carpenter LL, Frank E: Possible role of antidepressants in precipitating mania and hypomania in recurrent depression. Am J Psychiatry 1988;145:804-808.
71. Amsterdam JD, Garcia-Espana F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Schweizer E, Beasley C: Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol 1998;18:435-440.
72. Amsterdam J: Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode. J Clin Psychopharmacol 1998;18:414-417.